Pharmaceutical Industry

Page 16 of 100

The last time there was this much hype over a new drug was for Viagra, which was approved in 1998. Yet hurdles remain, when it comes to the ability of patients to access weight loss and anti-diabetes injectables like Zepbound and Wegovy: These drugs cost a lot, insurance coverage is spotty, and patients may need to take them indefinitely to avoid regaining weight.
Health

Weight-loss injectables like Zepbound are making as big of a splash as Viagra, if not bigger. What you need to know about the ‘miracle drugs’

By Emma Court, Madison Muller and Bloomberg
January 31, 2024
‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’, arguing they keep old drugs too pricey
Politics

‘We are using all the tools we have’: Lina Khan’s FTC takes aim at Big Pharma’s ‘patent thickets’, arguing they keep old drugs too pricey

By Elisabeth Rosenthal and KFF Health News
January 31, 2024
a laboratory monkey sitting in its cage in the breeding centre for cynomolgus macaques (longtail macaques) at the National Primate Research Center of Thailand
Features

What losing vision in one eye helped me understand about animal research

By
January 27, 2024
A long-tailed macaque being held by lab employees.
Features

Why Big Pharma can’t quit the lab monkey business

By
January 27, 2024
Big Pharma's favorite lab monkey, the long-tailed macaque.
Magazine

Big Pharma’s great lab monkey shortage: A crackdown on smuggling is causing chaos in America’s vital drug development pipeline

By
January 27, 2024
The Food and Drug Administration authorized importation of penicillin G benzathine made by a French company, Laboratoires Delbert. Pfizer’s Bicillin L-A, the only version of the drug available in the U.S., has been in short supply since April.
Health

FDA allows imports of French syphilis drug alternate during US penicillin shortage

By Ike Swetlitz and Bloomberg
January 10, 2024
person standing in front of a countdown clock in front of Paris's Eiffel Tower
Lifestyle

Gen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it’s a cool place to work

By
January 10, 2024
Alphabet’s Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery
Health

Alphabet’s Isomorphic Labs to collaborate with Novartis, Lilly on AI-driven drug discovery

By Susanne Barton and Bloomberg
January 8, 2024
Boston Scientific headquarters as pictured on Jan. 19, 2007. The company acquired device-maker Axonics Inc. for $2.7 billion on Monday.
Health

J&J, Merck, Boston Scientific go on $6.4B buying spree

By Fiona Rutherford and Bloomberg
January 8, 2024
Eli Lilly and Company says its popular drugs Mounjaro and Zepbound, also known as GLP-1s, are not meant for those without obesity or type 2 diabetes.

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of for diabetes and obesity

By
January 4, 2024
Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’
Health

Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’

By Ellie Harmsworth and Bloomberg
December 24, 2023
Pharma will pay rebates in 2024 on 48 drugs whose prices rose more than inflation this year: ‘Let’s call this for what it is—it simply is a rip off’
Health

Pharma will pay rebates in 2024 on 48 drugs whose prices rose more than inflation this year: ‘Let’s call this for what it is—it simply is a rip off’

By Amanda Seitz and The Associated Press
December 15, 2023
Why business should pay attention to the Supreme Court’s latest mifepristone case
Newsletters

Why business should pay attention to the Supreme Court’s latest mifepristone case

By Emma Hinchliffe and Joey Abrams
December 14, 2023
Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them
Commentary

Climate change is unleashing a tsunami of infectious diseases–and we have fewer and fewer drugs that can treat them

By
December 11, 2023
Joe Biden
Politics

The White House threatens to cancel the patents of taxpayer-funded drugs if they’re too expensive for patients to afford

By Amanda Seitz, Zeke Miller and The Associated Press
December 7, 2023

Most Popular